Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception

Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception

Background: Little is known about the cumulative effect of HIV antiretroviral therapy (ART) and hormonal contraception (HC) on metabolism and inflammation in HIV-positive women. Methods: We conducted a cross-sectional assessment of markers for carbohydrate, lipid, bone metabolism, inflammation and c...

Full description

Bibliographic Details
Main Authors:	Nadia Kancheva Landolt, Torsak Bunupuradah, Jullapong Achalapong, Pope Kosalaraksa, Witaya Petdachai, Chaiwat Ngampiyaskul, Sasiwimol Ubolyam, Narukjaporn Thammajaruk, Stephen Kerr, Jintanat Ananworanich
Format:	Article
Language:	English
Published:	Elsevier 2017-01-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020302971

Similar Items

Strategies to improve the uptake of effective contraception in perinatally HIV-infected adolescents
by: Nadia Kancheva Landolt, et al.
Published: (2017-07-01)

Contraceptive challenges in adolescents living with or at risk of HIV
by: Nadia Kancheva Landolt, et al.
Published: (2016-04-01)

Contraception in HIV-positive female adolescents
by: Ananworanich Jintanat, et al.
Published: (2011-06-01)

A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection
by: Ubolyam Sasiwimol, et al.
Published: (2008-10-01)

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
by: Phasomsap Chayapa, et al.
Published: (2011-10-01)

Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children
by: Torsak Bunupuradah, et al.
Published: (2015-07-01)

Effect of Egg and Milk Supplement on Breast Milk Volume at 48 and 72 Hours Postpartum: A Randomized-Controlled Trial
by: Jullapong Achalapong
Published: (2016-06-01)

High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
by: Puthanakit Thanyawee, et al.
Published: (2012-06-01)

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children
by: Jintanat Ananworanich, et al.
Published: (2015-07-01)

Double-Dose Hepatitis B Revaccination in Nonresponsive HIV-Infected Adolescents
by: Torsak Bunupuradah MD, et al.
Published: (2013-05-01)

Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals
by: Kramm Kenny, et al.
Published: (2006-12-01)

From transmission to transition: lessons learnt from the Thai paediatric antiretroviral programme.
by: Olivia Tulloch, et al.
Published: (2014-01-01)

Low-level genital HIV shedding in Thai HIV-infected women with suppressed plasma viral load after menopause: a longitudinal study
by: Nadia Kancheva Landolt, et al.
Published: (2017-10-01)

Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 cells/mm3 in Thailand
by: Win Min Han, et al.
Published: (2020-09-01)

Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings
by: Ramautarsing Reshmie, et al.
Published: (2010-06-01)

Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.
by: Tavitiya Sudjaritruk, et al.
Published: (2019-01-01)

Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study.
by: Vorapot Sapsirisavat, et al.
Published: (2016-01-01)

Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults
by: Anchalee Avihingsanon, et al.
Published: (2017-08-01)

Treatment outcomes and factors associated with mortality among individuals with both TB and HIV in the antiretroviral era in Thailand
by: Sivaporn Gatechompol, et al.
Published: (2019-10-01)

Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
by: Thanyawee Puthanakit, et al.
Published: (2018-04-01)

Safety of atazanavir/ritonavir with tenofovir disoproxil fumarate in HIV-infected adolescents
by: T. Bunupuradah, et al.
Published: (2014-04-01)

Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency.
by: Denise C Hsu, et al.
Published: (2013-01-01)

HIV cure research: a formidable challenge
by: Jintanat Ananworanich, et al.
Published: (2015-01-01)

Contraception for the HIV-Positive Woman: A Review of Interactions between Hormonal Contraception and Antiretroviral Therapy
by: Jennifer A. Robinson, et al.
Published: (2012-01-01)

Impact of antiretroviral treatment on height evolution of HIV infected children
by: Patrinee Traisathit, et al.
Published: (2019-08-01)

Association of <it>APOBEC3G</it> genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiency
by: Bunupuradah Torsak, et al.
Published: (2012-11-01)

How Much HIV is Alive? The Challenge of Measuring Replication Competent HIV for HIV Cure Research
by: Jintanat Ananworanich, et al.
Published: (2015-08-01)

Bringing Preventive RSV Monoclonal Antibodies to Infants in Low- and Middle-Income Countries: Challenges and Opportunities
by: Jintanat Ananworanich, et al.
Published: (2021-08-01)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
by: Samual A. Garner, et al.
Published: (2017-04-01)

Is there gender bias in HIV cure research? A case study of female representation at the 2015 HIV Persistence Workshop
by: Rowena Johnston, et al.
Published: (2016-04-01)

Potential risk of drug–drug interactions with hormonal contraceptives and antiretrovirals: prevalence in women living with HIV
by: Milena M Murray, et al.
Published: (2020-08-01)

Hormonal contraceptive use in HIV-infected women using antiretroviral therapy: a systematic review
by: Womack JA, et al.
Published: (2015-05-01)

Cervical cytological abnormalities and HPV infection in perinatally HIV–infected adolescents
by: J. Ananworanich, et al.
Published: (2015-01-01)

Predictors of disease progression in HIV infection: a review
by: Ananworanich Jintanat, et al.
Published: (2007-05-01)

Synthetic and mechanistic studies in carbohydrate chemistry
by: Yule, Kerr Carmichael
Published: (1964)

Prevalence of latent tuberculosis infection and feasibility of TB preventive therapy among Thai prisoners: a cross-sectional study
by: Sivaporn Gatechompol, et al.
Published: (2021-06-01)

Longitudinal patterns of unmet need for contraception among women living with HIV on antiretroviral therapy in South Africa.
by: Katherine B Rucinski, et al.
Published: (2018-01-01)

Contraceptive practices amongst HIV-positive women on antiretroviral therapy attending an ART clinic in South Africa
by: Ezekiel E. Oni, et al.
Published: (2013-05-01)

Assessing the capacity and findings of routine programmatic data in Kenya to guide decision-making around contraceptives and antiretroviral therapy
by: Beth A. Tippett Barr
Published: (2021-08-01)

Contraceptive use and pregnancy rates among women receiving antiretroviral therapy in Malawi: a retrospective cohort study
by: Hannock Tweya, et al.
Published: (2018-02-01)